Literature DB >> 36119845

ZNF516 suppresses stem cell-like characteristics by regulating the transcription of Sox2 in colorectal cancer.

Jifu E1, Zhengchun Kang1, Jie Yuan2, Zhaoming Wang1, Dafeng Tong1, Junjie Xing1.   

Abstract

This study aimed to explore the biological function and the molecular mechanism of the action of zinc-finger protein 516 (ZNF516) in suppressing stem cell-like characteristics and tumor progression in colorectal cancer (CRC). The expression profiles of ZNF516 in clinical samples and from The Cancer Genome Atlas (TCGA) CRC database were analyzed. Cell transfection was used to overexpress and knockdown ZNF516 in CRC cells. Cell counting kit-8 (CCK8) assays, transwell assays and flow cytometry were used to study cell proliferation, invasion and stem cell-like characteristics, respectively. Cycloheximide (CHX) was used to examine the effect of ZNF516 expression on Sox2 degradation. Finally, the effects of ZNF516 on tumor growth and metastasis were tested on xenograft tumor models and lung metastasis models in immunocompromised mice. We found that the expression level of ZNF516 was lower in TCGA CRC tissue and clinical CRC samples compared with that in normal colorectal mucosal cells. Overexpression of ZNF516 in CRC cells inhibited cell proliferation, colony formation, migration and invasion, whereas ZNF516 knockdown showed the opposite effects. In addition, ZNF516 overexpression inhibited the sphere-forming ability of CRC cells and suppressed the expression of CD133, CD44 and Oct4 in CRC cells. ZNF516 decreased the stability of Sox2 through a mechanism mediated by EGFR. By in vivo experiments using mouse tumor models, we further confirmed that ZNF516 attenuated tumor growth and alleviated lung metastasis in mice. In conclusion, ZNF516 functions as a tumor suppressor by regulating the transcription of Sox2 to inhibit cell proliferation, invasion, and the development of stem cell-like characteristics in CRC cells. AJCR
Copyright © 2022.

Entities:  

Keywords:  Sox2; ZNF516; colorectal cancer; stem cell-like characteristics; tumor progression

Year:  2022        PMID: 36119845      PMCID: PMC9442021     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   5.942


  29 in total

Review 1.  CD133 as a regulator of cancer metastasis through the cancer stem cells.

Authors:  Geou-Yarh Liou
Journal:  Int J Biochem Cell Biol       Date:  2018-11-03       Impact factor: 5.085

2.  When and how should surgery be performed in senior colorectal cancer patients?

Authors:  S H J Ketelaers; M Fahim; H J T Rutten; A B Smits; R G Orsini
Journal:  Eur J Surg Oncol       Date:  2020-01-09       Impact factor: 4.424

Review 3.  Genomics and emerging biomarkers for immunotherapy of colorectal cancer.

Authors:  Jakob Nikolas Kather; Niels Halama; Dirk Jaeger
Journal:  Semin Cancer Biol       Date:  2018-03-01       Impact factor: 15.707

Review 4.  Review on EGFR Inhibitors: Critical Updates.

Authors:  Davinder Singh; Bhupinder Kumar Attri; Rupinder Kaur Gill; Jitender Bariwal
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

5.  ZNF516 suppresses EGFR by targeting the CtBP/LSD1/CoREST complex to chromatin.

Authors:  Lifang Li; Xinhua Liu; Lin He; Jianguo Yang; Fei Pei; Wanjin Li; Shumeng Liu; Zhe Chen; Guojia Xie; Bosen Xu; Xia Ting; Zihan Zhang; Tong Jin; Xujun Liu; Wenting Zhang; Shuai Yuan; Ziran Yang; Chongyang Wu; Yu Zhang; Xiaohan Yang; Xia Yi; Jing Liang; Yongfeng Shang; Luyang Sun
Journal:  Nat Commun       Date:  2017-09-25       Impact factor: 14.919

6.  The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation.

Authors:  Liang-Yan Chen; Lian Wang; Yue-Xiang Ren; Zheng Pang; Yao Liu; Xiao-Dong Sun; Jian Tu; Zheng Zhi; Yan Qin; Li-Na Sun; Jian-Ming Li
Journal:  Mol Cancer       Date:  2020-11-23       Impact factor: 27.401

7.  Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.

Authors:  Yu-Chen Tang; Yan Zhang; Jin Zhou; Qiaoming Zhi; Meng-Yao Wu; Fei-Ran Gong; Meng Shen; Lu Liu; Min Tao; Bairong Shen; Dong-Mei Gu; Jie Yu; Meng-Dan Xu; Yuan Gao; Wei Li
Journal:  Int J Oncol       Date:  2017-11-01       Impact factor: 5.650

8.  Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity.

Authors:  Yasuhiko Komiya; Yumi Shimomura; Takuma Higurashi; Yutaka Sugi; Jun Arimoto; Shotaro Umezawa; Shiori Uchiyama; Mitsuharu Matsumoto; Atsushi Nakajima
Journal:  Gut       Date:  2018-06-22       Impact factor: 23.059

9.  EGFR enhances the stemness and progression of oral cancer through inhibiting autophagic degradation of SOX2.

Authors:  Xiao-Xi Lv; Xiao-Yu Zheng; Jiao-Jiao Yu; Hua-Rui Ma; Cheng Hua; Run-Tao Gao
Journal:  Cancer Med       Date:  2019-12-11       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.